Genetic Variations and Risk Factors on Medulloblastoma

Main Article Content

Isabel Soto Angulo
Jesús Salvador Valdez García
Jesús Francisco Balderrama Conde

Abstract

Medulloblastoma, a highly aggressive brain tumor, presents a complex clinical landscape driven by intricate genetic variations and diverse risk factors. This review delves into the tumor's genetic origins, emphasizing molecular subgroups and their prognostic implications. Examining risk factors such as age, gender, genetics, and ethnicity provides a holistic perspective. Unraveling hereditary forms sheds light on familial predispositions. Racial disparities underscore the importance of tailored approaches. Decoding the complexities surrounding medulloblastoma informs refined diagnostics and personalized treatments, offering hope for enhanced patient outcomes.

Article Details

How to Cite
Isabel Soto Angulo, Jesús Salvador Valdez García, & Jesús Francisco Balderrama Conde. (2023). Genetic Variations and Risk Factors on Medulloblastoma. International Journal of Medical Science and Clinical Research Studies, 3(12), 3004–3006. https://doi.org/10.47191/ijmscrs/v3-i12-14
Section
Articles

References

I. Kuzan-Fischer, C. M., Ferry, I., Guerreiro Stucklin, A. S., & Taylor, M. D. (2019). Medulloblastoma. Oncology of CNS Tumors, 539-553.

II. Lee, B., Mahmud, I., Pokhrel, R., Murad, R., Yuan, M., Stapleton, S., ... & Perera, R. J. (2022). Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs. Acta neuropathologica communications, 10(1), 25.

III. Fang, F. Y., Rosenblum, J. S., Ho, W. S., & Heiss, J. D. (2022). New developments in the pathogenesis, therapeutic targeting, and treatment of pediatric medulloblastoma. Cancers, 14(9), 2285.

IV. Gupta, T., Maitre, M., Sastri, G. J., Krishnatry, R., Shirsat, N., Epari, S., ... & Moiyadi, A. (2019). Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping. Journal of Neuro-Oncology, 144, 283-291.

V. Dasgupta, A., Maitre, M., Pungavkar, S., & Gupta, T. (2022). Magnetic resonance imaging in the Contemporary management of medulloblastoma: current and emerging applications. Medulloblastoma: Methods and Protocols, 187-214.

VI. Padovani, L., Horan, G., & Ajithkumar, T. (2019). Radiotherapy advances in paediatric medulloblastoma treatment. Clinical Oncology, 31(3), 171-181.

VII. Khan, R. B., Patay, Z., Klimo Jr, P., Huang, J., Kumar, R., Boop, F. A., ... & Robinson, G. W. (2021). Clinical features, neurologic recovery, and risk factors of postoperative posterior fossa syndrome and delayed recovery: a prospective study. Neuro-oncology, 23(9), 1586-1596.

VIII. Bagchi, A. (2019). Molecular Characteristics of Primary and Recurrent Medulloblastoma: Potential Insights to Alternative Therapy (Doctoral dissertation, Van Andel Research Institute).

IX. Stensvold, E. (2021). Paediatric and adolescent medulloblastoma and CNS-PNET in Norway 1974–2013: survival, regional differences, and late effects.

X. Trpchevska, N. (2022). Environmental and genetic risk factors for tinnitus (Doctoral dissertation, Karolinska Institutet (Sweden)).

XI. Menyhárt, O., & Győrffy, B. (2019). Principles of tumorigenesis and emerging molecular drivers of SHH‐activated medulloblastomas. Annals of Clinical and Translational Neurology, 6(5), 990-1005.

XII. Pál, M., Vetró, É., Nagy, N., Nagy, D., Horváth, E., Bokor, B. A., ... & Széll, M. (2023). Whole-Exome Sequencing Identified Two Novel Pathogenic Mutations in the PTCH1 Gene in BCNS. Current Issues in Molecular Biology, 45(7), 5293-5304.

XIII. Clark, R. D., & Curry, C. J. (2019). Genetic consultations in the newborn. Oxford University Press.

XIV. Villy, M. C., Warcoin, M., Filser, M., Buecher, B., Golmard, L., Suybeng, V., ... & Colas, C. (2023). First report of medulloblastoma in a patient with MUTYH‐associated polyposis. Neuropathology and Applied Neurobiology, 49(4), e12929.

XV. Mehta, A., & Gupta, G. (2019). Li–Fraumeni syndrome: A lesser known and investigated “cancer predisposition syndrome”. Journal of Current Oncology, 2(1), 1.

XVI. Ateş, E. A., Alavanda, C., Demir, Ş., Keklikkıran, Ç., Attaallah, W., Özdoğan, O. C., & Güney, A. İ. (2022). Mutation Spectrum of Familial Adenomatous Polyposis Patients in Turkish Population: Identification of 3 Novel APC Mutations. The Turkish Journal of Gastroenterology, 33(2), 81.

XVII. Gonçalves, F. G., Caschera, L., Teixeira, S. R., Viaene, A. N., Pinelli, L., Mankad, K., ... & Vossough, A. (2020). Intracranial calcifications in childhood: Part 1. Pediatric Radiology, 50, 1424-1447.

XVIII. Marcotte, E. L., Domingues, A. M., Sample, J. M., Richardson, M. R., & Spector, L. G. (2021). Racial and ethnic disparities in pediatric cancer incidence among children and young adults in the United States by single year of age. Cancer, 127(19), 3651-3663.

Most read articles by the same author(s)